LANDINE MICHAEL J
Known title: SVP, Corp Dev., Alkermes, Inc.CIK: 0001235600
Associated companies
Transaction History
| ALKS | ▲ Buy | Option Exercise | 4,077 | — | 2/23/2024 | View on chart |
| ALKS | ▼ Sell | Tax Withholding | 1,811 | $54K | 2/23/2024 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 5,654 | — | 2/22/2024 | View on chart |
| ALKS | ▼ Sell | Tax Withholding | 1,929 | $56K | 2/22/2024 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 5,461 | — | 2/20/2024 | View on chart |
| ALKS | ▼ Sell | Tax Withholding | 1,606 | $49K | 2/20/2024 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 4,448 | — | 2/18/2024 | View on chart |
| ALKS | ▼ Sell | Tax Withholding | 1,308 | $42K | 2/18/2024 | View on chart |
| ALKS | ▼ Sell | Tax Withholding | 3,183 | $85K | 2/8/2024 | View on chart |
| ALKS | ▲ Buy | Grant | 21,485 | — | 2/8/2024 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 5,544 | — | 2/22/2023 | View on chart |
| ALKS | ▼ Sell | Tax Withholding | 2,462 | $68K | 2/22/2023 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 5,825 | — | 2/21/2023 | View on chart |
| ALKS | ▼ Sell | Tax Withholding | 2,587 | $72K | 2/21/2023 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 5,354 | — | 2/20/2023 | View on chart |
| ALKS | ▼ Sell | Tax Withholding | 2,378 | $67K | 2/20/2023 | View on chart |
| ALKS | ▲ Buy | Grant | 11,770 | — | 2/20/2023 | View on chart |
| ALKS | ▼ Sell | Tax Withholding | 5,226 | $147K | 2/20/2023 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 4,361 | — | 2/18/2023 | View on chart |
| ALKS | ▼ Sell | Tax Withholding | 2,065 | $58K | 2/18/2023 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 50,000 | $828K | 5/17/2022 | View on chart |
| ALKS | ▼ Sell | Open Market | 50,000 | $1.5M | 5/17/2022 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 25,000 | $414K | 5/10/2022 | View on chart |
| ALKS | ▼ Sell | Open Market | 25,000 | $680K | 5/10/2022 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 25,000 | $414K | 5/3/2022 | View on chart |
| ALKS | ▼ Sell | Open Market | 25,000 | $715K | 5/3/2022 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 5,543 | — | 2/22/2022 | View on chart |
| ALKS | ▼ Sell | Tax Withholding | 2,462 | $62K | 2/22/2022 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 5,825 | — | 2/21/2022 | View on chart |
| ALKS | ▼ Sell | Tax Withholding | 2,587 | $65K | 2/21/2022 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 5,354 | — | 2/20/2022 | View on chart |
| ALKS | ▼ Sell | Tax Withholding | 2,368 | $59K | 2/20/2022 | View on chart |
| ALKS | ▼ Sell | Tax Withholding | 1,620 | $43K | 2/16/2022 | View on chart |
| ALKS | ▲ Buy | Option Exercise | 3,375 | — | 2/16/2022 | View on chart |
| ALKS | ▲ Buy | Grant | 8,031 | $0 | 9/14/2021 | View on chart |
| ALKS | ▼ Sell | Tax Withholding | 3,566 | $109K | 9/14/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
Baird Highlights Growth Potential for Alkermes plc (ALKS)
Baird has highlighted Alkermes plc as a company with promising growth potential, citing its pipeline and recent developments. A Yahoo article compares Alkermes to LQDA, discussing which biotech may be more attractive for investors. The stock is currently trading near its 200‑day moving average and close to a key support level of $48.74, while analysts average a target of $56.56.
Baird Highlights Growth Potential for Alkermes plc (ALKS). Baird has highlighted Alkermes plc as a company with promising growth potential, citing its pipeline and recent developments. A Yahoo article compares Alkermes to LQDA, discussing which biotech may be more attractive for investors. The stock is currently trading near its 200‑day moving average and close to a key support level of $48.74, while analysts average a target of $56.56.